Stay updated on Arbaclofen in Children and Adolescents With ASD Clinical Trial
Sign up to get notified when there's something new on the Arbaclofen in Children and Adolescents With ASD Clinical Trial page.

Latest updates to the Arbaclofen in Children and Adolescents With ASD Clinical Trial page
- Check7 days agoChange DetectedA banner announces an NIH website transition and links to updates and FAQs, including a notice about terminology changing from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check14 days agoChange DetectedThe footer now identifies the site revision as v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check21 days agoChange DetectedThe footer site revision changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows a 403 Forbidden error with minimal navigation (e.g., Home and Revision information), replacing the previous detailed study content and related metadata.SummaryDifference21%

- Check63 days agoChange DetectedThe page now displays a new revision tag, v3.6.6, replacing the previous v3.6.5, representing a minor internal update to the study details page.SummaryDifference0.0%

- Check70 days agoChange DetectedA note indicating NIH funding for 2018 was added, reflecting NIH support for the study.SummaryDifference0.0%

Stay in the know with updates to Arbaclofen in Children and Adolescents With ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arbaclofen in Children and Adolescents With ASD Clinical Trial page.